FineMark National Bank & Trust Sells 2,471 Shares of Danaher Co. (NYSE:DHR)

FineMark National Bank & Trust reduced its position in shares of Danaher Co. (NYSE:DHR) by 3.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 77,010 shares of the conglomerate’s stock after selling 2,471 shares during the period. FineMark National Bank & Trust’s holdings in Danaher were worth $17,678,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new position in Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC acquired a new position in Danaher in the fourth quarter worth $31,000. Teachers Insurance & Annuity Association of America bought a new stake in shares of Danaher during the third quarter worth $39,000. Finally, Pineridge Advisors LLC increased its stake in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a report on Friday, December 13th. The Goldman Sachs Group raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price target for the company in a report on Friday. Barclays reduced their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Wells Fargo & Company lowered their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Five investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $278.24.

Danaher Price Performance

DHR opened at $212.97 on Tuesday. The company has a fifty day simple moving average of $216.92 and a 200 day simple moving average of $238.13. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market cap of $152.21 billion, a P/E ratio of 40.33, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 earnings per share. On average, research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is presently 24.24%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.